Evidence map›Paper›PMID 17129374›Full record

ArticleArthritis research & therapy2006

Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections.

Siva Kanangat, Arnold Postlethwaite, Karen Hasty, Andrew Kang, Mark Smeltzer, Whitney Appling, Dennis Schaberg

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Pathogens (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. The role of the skin microbiome in atopic dermatitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2019
    Review
  12. Article
  13. Pathogenesis ofFrontiers in immunology · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Siva KanangatDepartment of Medicine, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38163, USA. skanangat@utmem.edu
Arnold Postlethwaite
Karen Hasty
Andrew Kang
Mark Smeltzer
Whitney Appling
Dennis Schaberg
University of Tennessee Health Science Center · USVA Greater Los Angeles Healthcare System · USVeterans Health Administration · US

Funding

IL-1 and IL-1ra Stimulation of S aureus ReplicationR03AR047936 · NIAMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KANANGAT, SIVADASAN · 2001 to 2003
$213k
NIAMS NIH HHS R03 AR047936NIAMS NIH HHS R03 AR47936-01
6 · The paper itself

Abstract

Infections of body tissue by Staphylococcus aureus are quickly followed by degradation of connective tissue. Patients with rheumatoid arthritis are more prone to S. aureus-mediated septic arthritis. Various types of collagen form the major structural matrix of different connective tissues of the body. These different collagens are degraded by specific matrix metalloproteinases (MMPs) produced by fibroblasts, other connective tissue cells, and inflammatory cells that are induced by interleukin-1 (IL-1) and tumor necrosis factor (TNF). To determine the host's contribution in the joint destruction of S. aureus-mediated septic arthritis, we analyzed the MMP expression profile in human dermal and synovial fibroblasts upon exposure to culture supernatant and whole cell lysates of S. aureus. Human dermal and synovial fibroblasts treated with cell lysate and filtered culture supernatants had significantly enhanced expression of MMP-1, MMP-2, MMP-3, MMP-7, MMP-10, and MMP-11 compared with the untreated controls (p < 0.05). In the S. aureus culture supernatant, the MMP induction activity was identified to be within the molecular-weight range of 30 to >50 kDa. The MMP expression profile was similar in fibroblasts exposed to a combination of IL-1/TNF. mRNA levels of several genes of the mitogen-activated protein kinase (MAPK) signal transduction pathway were significantly elevated in fibroblasts treated with S. aureus cell lysate and culture supernatant. Also, tyrosine phosphorylation was significantly higher in fibroblasts treated with S. aureus components. Tyrosine phosphorylation and MAPK gene expression patterns were similar in fibroblasts treated with a combination of IL-1/TNF and S. aureus. Mutants lacking staphylococcal accessory regulator (Sar) and accessory gene regulator (Agr), which cause significantly less severe septic arthritis in murine models, were able to induce expression of several MMP mRNA comparable with that of their isogenic parent strain but induced notably higher levels of tissue inhibitors of metalloproteinases (TIMPs). To our knowledge, this is the first report of induction of multiple MMP/TIMP expression from human dermal and synovial fibroblasts upon S. aureus treatment. We propose that host-derived MMPs contribute to the progressive joint destruction observed in S. aureus-mediated septic arthritis.

Indexed as

Arthritis, InfectiousArthritis, RheumatoidCells, CulturedEnzyme-Linked Immunosorbent AssayFibroblastsGene ExpressionGene Expression ProfilingHumansMatrix MetalloproteinasesMitogen-Activated Protein Kinase KinasesOsteoarthritisReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSkinSoft Tissue InfectionsStaphylococcal InfectionsMatrix MetalloproteinasesMitogen-Activated Protein Kinase KinasesRNA, MessengerTissue Inhibitor of Metalloproteinases

Identifiers

PMID17129374
PMCPMC1794521
OpenAlexW2164217046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.